
Journal of Medicinal Chemistry p. 1295 - 1299 (1984)
Update date:2022-08-05
Topics:
Strazzolini, Paolo
Malabarba, Adriano
Ferrari, Pietro
Grandi, Maria
Cavalleri, Bruno
L-Alanosine <3-(hydroxynitrosoamino)-L-alanine> is an antitumor antibiotic that at the present is undergoing phase II clinical trials.Its mode of action as well as its metabolism has been extensively studied, and the metabolite N-<(5-amino-1-β-D-ribofuran
View MoreContact:13357117572
Address:No.149 Shiji dadao Road.
Contact:410-273-7300; 800-221-3953
Address:4609 Richlynn Dr., PO Box 369, Belcamp, MD, 21017-0369, USA
Contact:86-25-84683399
Address:605, Phoenix Herui Plaza, No.389, South Taiping Road, Nanjing, China 210002
Shenyang NovPharm Technology Co., Ltd.
Contact:.+86-24-24165786
Address:Room 306, Hongjin Mansion, No. 36-1, Wanliutang Rd., Shenhe District, Shenyang, Liaoning, P.R.C.
Contact:+86-577-65618087-605
Address:Room 402, Unit 4 Xinhu Bldg. Waitan Ruian City, Zhejiang China.
Doi:10.1021/op060125+
(2006)Doi:10.1039/b607710b
(2006)Doi:10.1016/j.jorganchem.2006.05.041
(2006)Doi:10.1016/S0040-4020(01)82384-X
(1993)Doi:10.1016/0022-328X(84)80108-4
(1984)Doi:10.1021/jo00193a008
(1984)